Lacosamide 72865-0235
Product NDC
72865-0235- Manufacturer
- Xlcare Pharmaceuticals Inc.
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- January 25, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA216335
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(1)
10 VIAL, GLASS in 1 CARTON (72865-235-10) / 20 mL in 1 VIAL, GLASS (72865-235-01)